glp-1 ileus legal team in louisiana law office louisiana semaglutide ileus lawyer semaglutide gi obstruction lawyer in louisiana Ozempic Stomach Paralysis Lawsuit semaglutide gastric intestinal obstruction lawsuit

Doctors are allowed to prescribe medications like this off-label, meaning for indications not specifically outlined by the FDA

a) Insulin only b) GLP1 and GIP c) Glucagon only d) Amylin & somatostatin Answer: b) GLP1 and GIP The glucose-lowering effect is: a) Constant b) Glucose-dependent c) Hypoglycemia-prone d) Insulin-independent Answer: b) Glucose-dependent Sitagliptin is primarily excreted via: a) Feces b) Urine c) Bile d) Sweat Answer: b) Urine A rare but serious side effect is: a) Hypoglycemia b) Pancreatitis c) Hypothyroidism d) Bladder cancer Answer: b) Pancreatitis Protein binding is approximately: a) 10% b) 38% c) 80% d) 99% Answer: b) 38% DPP4 inhibitors differ from GLP1 agonists by: a) Oral vs injection b) Cost only c) Efficacy only d) Indication only Answer: a) Oral vs injection Combination with sulfonylureas increases risk of: a) Pancreatitis b) Heart failure c) Hypoglycemia d) Weight gain Answer: c) Hypoglycemia Dose scheduling is: a) Multiple times daily b) Once daily c) Every other day d) Weekly Answer: b) Once daily Sitagliptin therapy is least likely to cause: a) Hypoglycemia b) Weight gain c) Nasopharyngitis d) Pancreatitis Answer: a) Hypoglycemia Onset of action occurs within: a) Minutes b) Hours c) Days d) Weeks Answer: b) Hours Compared to saxagliptin, sitagliptin has: a) Higher potency b) Lower potency c) Similar profile d) Different mechanism Answer: c) Similar profile Sitagliptin should be dose-adjusted for: a) Liver disease b) Renal impairment c) Hypothyroidism d) Pregnancy Answer: b) Renal impairment Weight effect of sitagliptin is: a) Weight gain b) Weight loss c) Weight neutral d) Unknown Answer: c) Weight neutral Sitagliptin carries risk of heart failure

Using them purely for cosmetic weight loss while high-risk patients cannot access those, raises ethical and healthcare equity concerns.Is there a danger that patients may stop statins, BP medicines, or lifestyle measures thinking GLP-1 is a magic bullet?Yes, that is a real concern

Noriega, D